BOTH Co2Cl AND
Cl2Co MODELS IMPROVE CARDIOVASCULAR
SCIENTIFIC INNOVASTION
Indeed, more innovative technologies and discoveries will help to
improve the control and prevention of CVD. For example, innovative
digital health interventions can be an effective strategy to reduce
cardiovascular risk,22 clonal hematopoiesis of
indeterminate potential links to an increased risk of CVD due to the
role of inflammasomes,23 polygenic risk scores-triaged
coronary artery calcium score for subclinical coronary artery
disease.24 In fact, moderate and severe chronic kidney
disease measures may improve CVD risk prediction,25and CVD events (such as AF, HF, and stroke) strongly and independently
associate with future risk of kidney failure with replacement
therapy.26 As a potential means for CVD risk
stratification, artificial intelligence-based ocular image
analysis27 contributes to the identification and
prediction of CVD risks and events. Chinese herbal remedies have shown
promise in regulating cardiac ion channels and providing new
opportunities for developing novel anti-arrhythmic
agents,28 but more high-quality studies like RCTs are
needed for further clinical application.29 However,
all these innovative technologies and discoveries also need to translate
into clinical application by both
Co2Cl &
Cl2Co models. And after ethics
approval from the local ethics committees, a series of findings can be
disseminated through scientific meetings and peer-reviewed journals and
via social media.22